27 July 2020 : Database Analysis
Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer
Yanyan Feng1AC, Chunguang Guo2BC, Hesong Wang1B, Lu Zhao1CF, Wei Wang1C, Ting Wang1BC, Yuyin Feng3C, Kai Yuan1BCDF, Guangrui Huang3AEG*DOI: 10.12659/MSM.923531
Med Sci Monit 2020; 26:e923531
Figure 6 GO analysis and KEGG pathway analysis of FGL2-related genes in breast cancer. (A) GO analysis of FGL2 in breast cancer with the TCGA database. FGL2 was correlated with the immune response, signal transduction, and inflammatory response. (B) KEGG pathway analysis of FGL2 in breast cancer with the TCGA database. FGL2 was correlated with cell adhesion molecules and cytokine-cytokine receptor interactions. (C) GO analysis of FGL2 in breast cancer with the ArrayExpress dataset. FGL2 was correlated with the immune response, signal transduction, and inflammatory response. (D) KEGG pathway analysis of FGL2 in breast cancer with the ArrayExpress dataset. FGL2 was correlated with HTLV-1 infection and cell adhesion molecules.